This course includes the recording of a live Instructional Course from the 2026 AOSSM Annual Meeting.Please Note: The Q&A QR code in the Recording is currently inactive. Any questions submitted through it will not be monitored or answered.
Course Description:
This ICL will cover the breadth of UCL injuries in baseball players including diagnosis, current imaging strategies (FEVER MRI, stress US, etc), and treatment options. We will discuss UCL repair as well as the up and coming hybrid technique. We will discuss the most up to date outcomes as well as our accelerated and standard length return to throwing programs. Finally, we will discuss the pitch smart guidelines as well as some modifications that are coming.
Learning Objectives:
Faculty:
ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit. AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credit™ participants must complete the activity and online evaluation. No hard copy submissions will be accepted.
American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP# P460) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers. This program is eligible for a maximum of 1 Category A CEUs. ATs should claim only those hours actually spent in the educational program.
Brandon Erickson, MD
Arthrex, Inc: Consultant (Ongoing)|Smith & Nephew: Consultant (Ongoing)
Eric Bowman, MD
"has no relevant financial relationship(s) with ineligible companies to disclose"
Peter Chalmers , MD
Advita: Consultant (Ongoing)|Advita: Royalties (Ongoing)|Advita: Speaker (Ongoing)|Cinch: Own stock options in a privately held ineligible company (Ongoing)|Depuy: Consultant (Ongoing)|Depuy: Royalties (Ongoing)|Depuy: Speaker (Ongoing)|MLB: Independent Contractor (Ongoing)|Responsive Arthroscopy: Royalties (Ongoing)|TitinKM Biomedical: Own stock options in a privately held ineligible company (Ongoing)
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.
ORIGINAL RELEASE DATE: 8/1/2026EXPIRATION DATE: 7/31/2029